Pfizer Says Zoloft Defect Claims Still Suffer Lack Of Science
Pfizer Inc. has continued to fight parents targeting the drugmaker in multidistrict litigation over the alleged birth defect risks of its antidepressant Zoloft, arguing in Pennsylvania federal court that a recent...To view the full article, register now.
Already a subscriber? Click here to view full article